| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.26M | 83.07M | 106.04M | 104.51M | 60.40M | 45.16M |
| Gross Profit | 13.69M | 14.40M | 18.73M | 21.09M | 12.24M | 7.33M |
| EBITDA | 1.17M | -323.37K | 6.58M | 8.27M | 3.93M | -1.89M |
| Net Income | -1.68M | -3.85M | 909.41K | 8.64M | 1.32M | -5.15M |
Balance Sheet | ||||||
| Total Assets | 48.86M | 58.17M | 68.37M | 78.50M | 43.80M | 26.29M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 0.00 | 0.00 | -1.94M | -7.48M | -1.78M |
| Total Debt | 18.84M | 17.70M | 31.00M | 39.59M | 23.89M | 12.63M |
| Total Liabilities | 29.31M | 38.56M | 45.83M | 56.09M | 32.08M | 15.73M |
| Stockholders Equity | 19.55M | 19.61M | 22.54M | 22.41M | 11.72M | 10.56M |
Cash Flow | ||||||
| Free Cash Flow | 4.59M | 9.97M | 12.00M | -10.67M | -9.26M | 10.22M |
| Operating Cash Flow | 5.04M | 10.39M | 12.69M | -8.57M | -9.22M | 10.22M |
| Investing Cash Flow | -453.25K | -414.09K | -676.64K | -2.10M | 40.11K | 1.43K |
| Financing Cash Flow | -4.59M | -9.97M | -12.01M | 10.67M | 9.18M | -10.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $1.23B | 10.29 | 18.06% | 3.57% | 9.24% | 6.35% | |
74 Outperform | C$195.19M | 8.87 | 11.94% | ― | -0.39% | -86.01% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | C$348.13M | 17.95 | 3.20% | ― | -8.13% | -28.00% | |
56 Neutral | C$400.15M | -49.68 | -1.94% | ― | -9.19% | -119.27% | |
49 Neutral | C$10.79M | -50.30 | -0.80% | ― | -75.46% | -100.66% | |
46 Neutral | C$5.55M | -3.30 | -8.25% | ― | -11.17% | 6.19% |
Bri-Chem Corp. reported a significant decline in its financial performance for the fourth quarter of 2024, with consolidated sales dropping by 23% to $20.6 million due to decreased U.S. drilling activity. The company’s adjusted EBITDA and operating earnings also saw substantial decreases, alongside a notable reduction in working capital, which was impacted by a loan classification change. Despite these challenges, Bri-Chem received a waiver for a covenant breach from its lender, indicating ongoing financial adjustments and potential future stability.